SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries
7 references·2 citing·38 second hop
An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries (2017)An assessment of differences in costs and…Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios (2013)Prevalence of human immunodef…Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)Model Parameter Estimation an…Risk‐based decision‐making for blood safety: preliminary report of a consensus conference (2011)Risk‐based decision‐making fo…Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations (2009)Methods for assessing the cos…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands (2009)BLOOD DONORS AND BLOOD COLLEC…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study (2021)An international comparison o…Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries (2020)Quality and safety measures i…Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Decision Modelling For Health Economic Evaluation (2006)Discounting and decision making in the economic evaluation of health-care technologies (2010)Social Return on Investment (SROI) methodology to account for value for money of public health interventions: a systematic review (2015)An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations (2021)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations (2017)Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa (2017)HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men (2020)World Development Report 1990. (1990)Health economics of blood transfusion safety – focus on sub-Saharan Africa (2009)Residual risk and waste in donated blood with pooled nucleic acid testing (2016)Robust Postdonation Blood Screening Under Prevalence Rate Uncertainty (2017)Network meta‐analysis for indirect treatment comparisons (2002)Uncertain Judgements: Eliciting Experts' Probabilities (2006)Conceptualizing a Model (2012)Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7 (2012)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2017)Addressing gaps in international blood availability and transfusion safety in low‐ and middle‐income countries: a NHLBI workshop (2018)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Prevention of transfusion-transmitted infections (2019)Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men (2023)Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re‐emergence of syphilis and HIV pre‐exposure prophylaxis use (2024)The Politics of Blood (2012)Risk‐based decision making and ethical considerations in donor compensation for plasma‐derived medicinal products (2016)Risk‐based decision making in transfusion medicine (2018)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 2012Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6716 cited
  • 2009Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations321 cited
  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 2013Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios50 cited
  • 2011Risk‐based decision‐making for blood safety: preliminary report of a consensus conference38 cited
  • 2009BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands31 cited

Cited by

  • 2021An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study13 cited
  • 2020Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work